Cotton Brandi P, Lohman Matthew C, Brooks Jessica M, Whiteman Karen L, Bao Yuhua, Greenberg Rebecca L, Bruce Martha L
Brandi P. Cotton, PhD, MSN, APRN, is a Postdoctoral Research Fellow, Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Matthew C. Lohman, PhD, is a Postdoctoral Research Fellow, Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Jessica M. Brooks, PhD, is a Postdoctoral Research Fellow, Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Karen L. Whiteman, PhD, is a Postdoctoral Research Fellow, Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Yuhua Bao, PhD, is an Associate Professor, Department of Healthcare Policy and Research and Department of Psychiatry, Weill Cornell Medical College, New York, New York. Rebecca L. Greenberg, MS, is a Clinical Database and Statistics Consultant, Self-Employed, Chappaqua, New York. Martha L. Bruce, PhD, MPH, is a Professor, Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
Home Healthc Now. 2017 Jun;35(6):304-313. doi: 10.1097/NHH.0000000000000553.
High rates of controlled prescription drugs are associated with cognitive impairment, falls, and misuse and dependence. Little is known about the prevalence of these medications among older adults receiving home healthcare. The purpose of this study was to determine the frequency of, and the factors related to, opioid analgesics, benzodiazepines (BNZ), and nonbenzodiazepine (NBNZH) hypnotics among a large sample of older adults entering home healthcare services. The data came from administrative records of 133 Certified Home healthcare Agencies located across 32 states. Patients (age ≥ 65) receiving Medicare home healthcare services and who received a start-of-care Medicare OASIS assessment between January 1, 2013, and December 31, 2014, were included in the study (n = 87,780). Rates of controlled medication use were compared across patient-level sociodemographic, clinical, functional, and environmental variables. The prevalence of controlled medication was high, with 58% prescribed at least one class of controlled drug, 44% were prescribed an opioid, 19% were prescribed a BNZ, and almost 7% were prescribed a NBZDH. Factors independently associated with higher levels of controlled medication usage include younger-old age, white race, postsurgical status, injuries, referral from inpatient settings, and rural location. Home healthcare clinicians are well positioned to review and reconcile medication, oversee referrals and follow-up care, and provide ongoing assessment of risk regarding the use of opioids, BNZ, and hypnotics among home healthcare patients.
高比例的管制处方药与认知障碍、跌倒、药物滥用及药物依赖有关。对于接受家庭医疗保健服务的老年人中这些药物的使用情况,我们知之甚少。本研究的目的是确定在大量开始接受家庭医疗保健服务的老年人样本中,阿片类镇痛药、苯二氮䓬类药物(BNZ)和非苯二氮䓬类催眠药(NBNZH)的使用频率及其相关因素。数据来自位于32个州的133家经认证的家庭医疗保健机构的行政记录。纳入研究的患者为年龄≥65岁、在2013年1月1日至2014年12月31日期间接受医疗保险家庭医疗保健服务且接受了护理开始时医疗保险OASIS评估的患者(n = 87,780)。比较了不同患者层面的社会人口统计学、临床、功能和环境变量的管制药物使用率。管制药物的使用率很高,58%的患者至少开具了一类管制药物,44%的患者开具了阿片类药物,19%的患者开具了BNZ,近7%的患者开具了NBZDH。与较高水平的管制药物使用独立相关的因素包括老年中的较年轻者、白人种族、术后状态、损伤、来自住院环境的转诊以及农村地区。家庭医疗保健临床医生有能力审查和核对药物、监督转诊和后续护理,并对家庭医疗保健患者使用阿片类药物、BNZ和催眠药的风险进行持续评估。